Skip to main content

Ileal Pouch

1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

ExeGi Pharma
ExeGi PharmaMD - Rockville
1 program
1
EXE-346Phase 1/21 trial
Active Trials
NCT05938465Recruiting50Est. Jun 2026

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
ExeGi PharmaEXE-346

Clinical Trials (1)

Total enrollment: 50 patients across 1 trials

Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)

Start: Nov 2023Est. completion: Jun 202650 patients
Phase 1/2Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 50 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.